Assessment of Respiratory Symptoms After Corticosteroid Treatment Period Using Impedance Pneumography
IP-ASTMA_2
1 other identifier
observational
68
1 country
2
Brief Summary
INTRODUCTION Lung function assessment of preschool children is hindered by their limited co-operation in conventional tests such as peak expiratory flow (PEF) or spirometry and the methods available for younger children are, again, laborious and time consuming. However, impedance pneumography (IP) records indices of airway obstruction during normal sleep at home and has been shown accurate in wheezy preschool children (Seppä et al. J Appl Physiol 2013). AIM OF THE STUDY The general purpose of this study is to assess the clinical value of the information provided by overnight home recording of tidal breathing by means of IP technique in young children with asthmatic symptoms and inhaled corticosteroid (ICS) medication. The main hypothesis is that IP measurement can distinguish between groups whose asthmatic symptoms recur or do not recur after ending the ICS drug treatment period. METHODS The study recruits 1-5 year old children (n=75) who have presented at the emergency room due to obstructive bronchitis and for whom an ICS drug treatment period has been prescribed based on the national guidelines. The subjects will perform three overnight IP measurements at home at two weeks intervals close to and after ending of the treatment period. SIGNIFICANCE OF THE STUDY Being an affordable, simple and convenient ambulatory measurement method, IP may bring needed objectivity to asthma diagnostics and asthma drug response assessment in young children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2014
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 13, 2014
CompletedFirst Posted
Study publicly available on registry
June 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2020
CompletedMarch 30, 2020
March 1, 2020
3.5 years
June 13, 2014
March 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ability of IP measurement to distinguish patient subgroups
Comparison of the measures derived from the IP measurement (the investigational device) between the subgroups in the cohort at three times: 1 wk before end of ICS period, 1-2 wk after ending ICS period, 3-4 wk after ending ICS period
1 wk before to 4 weeks after end of ICS period
Study Arms (1)
Obstructive bronchitis
1-5 year old patients who have visited the TAYS emergency room due to obstructive bronchitis and have been instructed to begin a three-month period of inhaled corticosteroid (ICS) treatment as per national guidelines.
Eligibility Criteria
1-5 year old patients who have visited the TAYS emergency room due to obstructive bronchitis and have been instructed to begin a three-month period of inhaled corticosteroid (ICS) treatment as per national guidelines.
You may qualify if:
- Age 1-5 yrs
- Recurrent obstructive bronchitis
- Inhaled corticosteroid treatment has been prescribed
You may not qualify if:
- Laryngeal disease
- Tracheobronchial malacia
- Parenchymal lung disease
- History of bronchopulmonary dysplasia
- Active implantable medical such as pacemakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tampere University of Technologycollaborator
- Tampere University Hospitallead
Study Sites (2)
TAYS Allergiakeskus
Tampere, 33521, Finland
Tampere University of Technology / ELT Dept
Tampere, 33720, Finland
Related Publications (1)
Seppa VP, Pelkonen AS, Kotaniemi-Syrjanen A, Makela MJ, Viik J, Malmberg LP. Tidal breathing flow measurement in awake young children by using impedance pneumography. J Appl Physiol (1985). 2013 Dec;115(11):1725-31. doi: 10.1152/japplphysiol.00657.2013. Epub 2013 Oct 3.
PMID: 24092693BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Jussi Karjalainen, MD
Tampere University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 13, 2014
First Posted
June 17, 2014
Study Start
May 1, 2014
Primary Completion
November 1, 2017
Study Completion
March 27, 2020
Last Updated
March 30, 2020
Record last verified: 2020-03